DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
5.93
+0.51 (9.41%)
At close: Nov 14, 2025, 4:00 PM EST
5.72
-0.21 (-3.54%)
After-hours: Nov 14, 2025, 4:00 PM EST

DiaMedica Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3092321084299190
Upgrade
Market Cap Growth
67.20%115.41%157.97%-57.63%-48.10%226.30%
Upgrade
Enterprise Value
25418252651160
Upgrade
Last Close Price
5.425.432.841.583.7310.14
Upgrade
PB Ratio
5.475.702.111.312.247.30
Upgrade
P/TBV Ratio
5.985.702.111.312.247.30
Upgrade
Debt / Equity Ratio
0.010.010.010.020.000.01
Upgrade
Quick Ratio
10.558.2319.1215.4929.6913.73
Upgrade
Current Ratio
10.678.2819.2715.6129.8213.77
Upgrade
Return on Equity (ROE)
-64.12%-53.27%-46.77%-36.06%-38.81%-73.10%
Upgrade
Return on Assets (ROA)
-38.34%-33.18%-30.02%-21.89%-23.16%-42.73%
Upgrade
Return on Capital (ROIC)
-41.91%-36.05%-31.74%-22.92%-24.30%-46.79%
Upgrade
Earnings Yield
-10.34%-10.53%-17.98%-32.73%-13.78%-6.47%
Upgrade
FCF Yield
-8.99%-9.52%-17.40%-27.74%-12.45%-4.86%
Upgrade
Buyback Yield / Dilution
-13.70%-24.07%-23.16%-27.29%-32.48%-30.80%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q